Trial
NCT01362348
12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Macular Degeneration
Intervention
pazopanib eye drops
Why stopped
Lack of efficacy identified during a preliminary analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-21